gemcitabine has been researched along with degrasyn in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Chen, BW; Chen, W; Hu, L; Li, H; Liang, T; Liu, H; Ma, T; Shen, J; Zhang, B; Zhang, S; Zheng, X; Zhi, X; Zhou, Y | 1 |
2 other study(ies) available for gemcitabine and degrasyn
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
USP9X inhibition improves gemcitabine sensitivity in pancreatic cancer by inhibiting autophagy.
Topics: Animals; Autophagy; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyanoacrylates; Deoxycytidine; Drug Resistance, Neoplasm; Enzyme Inhibitors; Gemcitabine; Humans; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Pyridines; Ubiquitin Thiolesterase; Xenograft Model Antitumor Assays | 2018 |